secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K/A
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001193125-25-178993
Event type: m_and_a
Sentiment:  negative
Materiality: 0.65
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kineta acquisition closed; Q1 2025 financials show $1.7M net loss and $13.2M deficit
--------------------------------------------------------------------------------

- Cash $304K, total liabilities $14M, stockholders' deficit $13.2M as of March 31, 2025.
- Net loss attributable to Kineta for Q1 2025 was $1.676M vs $10.238M in Q1 2024 on reduced R&D spend.
- Accumulated deficit reached $184.6M; Kineta has going concern warning with insufficient cash for next 12 months.
- Merger consideration includes up to $16.5M initial stock, $6.5M delayed stock, $12M cash (net of exclusivity credits and working capital adjustments).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525178993/0001193125-25-178993-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525178993/d67982d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-178993

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer